Elevated activation of IgE-mediated immune pathways has been clinically observed in autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus and atopic diseases including atopic dermatitis, and asthma (17); however, the correlation between IgE and pathogenesis of AA remain unpredictable. This evidence concerns the gene IGHE and atopic eczema.